Literature DB >> 14574050

B-type natriuretic peptide: physiologic role and assay characteristics.

Hassan M E Azzazy1, Robert H Christenson.   

Abstract

The discovery of cardiac natriuretic peptides two decades ago has lead to considerable research to investigate their biochemical and physiological properties. Clearly the heart is not just a pump but is also an endocrine organ that together with the kidneys control volume overload. The natriuretic peptides are a group of structurally similar but genetically distinct peptides that exhibit diverse actions in cardiovascular, renal, and endocrine homeostasis. Atrial natriuretic peptide (ANP) and brain (or B-type) natriuretic peptide (BNP) are of myocardial cell origin. BNP is released mainly from the left ventricle in response to volume overload and has become the first biochemical marker for the identification of individuals with congestive heart failure (CHF). The development of assays, including rapid point-of-care tests, has made BNP measurement a clinical reality.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14574050     DOI: 10.1023/a:1026182912461

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  33 in total

Review 1.  Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use.

Authors:  F Boomsma; A H van den Meiracker
Journal:  Cardiovasc Res       Date:  2001-08-15       Impact factor: 10.787

Review 2.  Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease.

Authors:  B C Stein; R I Levin
Journal:  Am Heart J       Date:  1998-05       Impact factor: 4.749

3.  Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.

Authors:  P J Hunt; E A Espiner; M G Nicholls; A M Richards; T G Yandle
Journal:  J Clin Endocrinol Metab       Date:  1996-11       Impact factor: 5.958

4.  A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.

Authors:  R Kazanegra; V Cheng; A Garcia; P Krishnaswamy; N Gardetto; P Clopton; A Maisel
Journal:  J Card Fail       Date:  2001-03       Impact factor: 5.712

5.  Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice.

Authors:  D R Murdoch; J Byrne; J J Morton; T A McDonagh; S D Robb; S Clements; I Ford; J J McMurray; H J Dargie
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

6.  A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation.

Authors:  Stacey J Wieczorek; Alan H B Wu; Robert Christenson; Padma Krishnaswamy; Stephen Gottlieb; Thomas Rosano; David Hager; Nancy Gardetto; Albert Chiu; Kathryn R Bailly; Alan Maisel
Journal:  Am Heart J       Date:  2002-11       Impact factor: 4.749

7.  Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

Authors:  K Yamamoto; J C Burnett; M Jougasaki; R A Nishimura; K R Bailey; Y Saito; K Nakao; M M Redfield
Journal:  Hypertension       Date:  1996-12       Impact factor: 10.190

8.  Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans.

Authors:  D L Vesely; M A Douglass; J R Dietz; W R Gower; M T McCormick; G Rodriguez-Paz; D D Schocken
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

9.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

Authors:  M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton
Journal:  Lancet       Date:  1997-11-08       Impact factor: 79.321

10.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

View more
  2 in total

1.  B-type natriuretic Peptide in the critically ill with acute kidney injury.

Authors:  Massimo de Cal; Mikko Haapio; Dinna N Cruz; Paolo Lentini; Andrew A House; Ilona Bobek; Grazia M Virzì; Valentina Corradi; Flavio Basso; Pasquale Piccinni; Angela D'Angelo; Jamie W Chang; Mitchell H Rosner; Claudio Ronco
Journal:  Int J Nephrol       Date:  2011-06-22

2.  Levels of brain natriuretic peptide as a marker for the diagnosis and prognosis of acute ischemic stroke.

Authors:  Saadet Sayan; Dilcan Kotan
Journal:  Arch Med Sci Atheroscler Dis       Date:  2016-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.